Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Lymphoma
  Free Subscription

Articles published in
N Engl J Med
    September 2025
  1. OKADA S, Nishikubo M
    Subcutaneous Panniculitis-like T-Cell Lymphoma.
    N Engl J Med. 2025;393:1117.
    >> Share

    August 2025
  2. ALEMAN A, Van Oekelen O, Melnekoff DT, Grossman L, et al
    Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy.
    N Engl J Med. 2025;393:823-825.
    >> Share

  3. SVOBODA J, Hexner E, June CH
    Enhanced CAR T-Cell Therapy for Relapsed Lymphoma. Reply.
    N Engl J Med. 2025;393:620.
    >> Share

  4. VAIRAMOORTHY N, Kazi B, Patil V
    Enhanced CAR T-Cell Therapy for Relapsed Lymphoma.
    N Engl J Med. 2025;393:619-620.
    >> Share

    May 2025
  5. SVOBODA J, Landsburg DJ, Gerson J, Nasta SD, et al
    Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure.
    N Engl J Med. 2025;392:1824-1835.
    >> Share

  6. PRICA A, Roschewski M, Beale P, Pittaluga S, et al
    Glofitamab with Polatuzumab Vedotin in Refractory Burkitt's Lymphoma.
    N Engl J Med. 2025;392:1760-1762.
    >> Share

    February 2025
  7. HARRISON SJ, Touzeau C, Kint N, Li K, et al
    CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma.
    N Engl J Med. 2025;392:677-685.
    >> Share

  8. PERICA K, Jain N, Scordo M, Patel R, et al
    CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53.
    N Engl J Med. 2025;392:577-583.
    >> Share

    January 2025
  9. HERRERA AF, LeBlanc M, Friedberg JW
    Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma. Reply.
    N Engl J Med. 2025;392:102.
    >> Share

  10. SHIBUSAWA M, Tanimoto T
    Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
    N Engl J Med. 2025;392:101.
    >> Share

    October 2024
  11. ARMITAGE JO, Longo DL
    Therapy for Hodgkin's Lymphoma - Can It Get Any Better?
    N Engl J Med. 2024;391:1452-1454.
    >> Share

  12. HERRERA AF, LeBlanc M, Castellino SM, Li H, et al
    Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
    N Engl J Med. 2024;391:1379-1389.
    >> Share

  13. KOBBE G, Bruggemann M, Baermann BN, Wiegand L, et al
    Aggressive Lymphoma after CD19 CAR T-Cell Therapy.
    N Engl J Med. 2024;391:1217-1226.
    >> Share

    September 2024
  14. HAMILTON MP, Miklos DB, Alizadeh AA
    Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy. Reply.
    N Engl J Med. 2024;391:870-871.
    >> Share

  15. GODFREY J, Querfeld C, Song J
    Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.
    N Engl J Med. 2024;391:869-870.
    >> Share

    August 2024
  16. DORES GM, Morton LM
    T-Cell Neoplasms after B-Cell Neoplasms - The Pre-CAR T-Cell Era.
    N Engl J Med. 2024;391:662-664.
    >> Share

    June 2024
  17. GOLDSTEIN JS, Alizadeh AA
    ViPOR's Venom - Rationally Targeting DLBCL with Precision.
    N Engl J Med. 2024;390:2209-2211.
    >> Share

  18. MELANI C, Lakhotia R, Pittaluga S, Phelan JD, et al
    Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma.
    N Engl J Med. 2024;390:2143-2155.
    >> Share

  19. VELEANU L, Lamant L, Sibon D
    Brigatinib in ALK-Positive ALCL after Failure of Brentuximab Vedotin.
    N Engl J Med. 2024;390:2129-2130.
    >> Share

  20. OZDEMIRLI M, Loughney TM, Deniz E, Chahine JJ, et al
    Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy.
    N Engl J Med. 2024;390:2074-2082.
    >> Share

  21. HAMILTON MP, Sugio T, Noordenbos T, Shi S, et al
    Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.
    N Engl J Med. 2024;390:2047-2060.
    >> Share

    May 2024
  22. CHEN ST, Cochran RL, Jain S, Stagner AM, et al
    Case 15-2024: A 73-Year-Old Woman with Worsening Rash.
    N Engl J Med. 2024;390:1803-1813.
    >> Share

    April 2024
  23. HU Y, Zhang M, Yang T, Mo Z, et al
    Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.
    N Engl J Med. 2024;390:1467-1480.
    >> Share

    March 2024
  24. VIPLER B
    "What's Lymphoma?" - Risks Posed by Immediate Release of Test Results to Patients.
    N Engl J Med. 2024;390:1064-1066.
    >> Share

    December 2023
  25. CHENG JW, Li JH
    Intravascular Large B-Cell Lymphoma.
    N Engl J Med. 2023;389:2188.
    >> Share

    September 2023
  26. WESTIN JR, To C, Locke FL
    Axicabtagene Ciloleucel in Large B-Cell Lymphoma. Reply.
    N Engl J Med. 2023;389:1152-1153.
    >> Share

  27. ZHAO WL, Wu DP, Hu Y
    Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
    N Engl J Med. 2023;389:1152-1153.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016